Approval · Notice of Compliance 37247 · 2026
ROTATEQ: Notice of Compliance 37247
Issued April 1, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37247
- Date
- April 1, 2026
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ROTATEQ | Not yet assigned | — |
Medicinal ingredients
- ROTAVIRUS VACCINE, LIVE, ORAL, TYPE G1 (HUMAN) 0.0002 UNIT per DOSE
- ROTAVIRUS VACCINE, LIVE, ORAL, TYPE G2 (HUMAN) 0.0003 UNIT per DOSE
- ROTAVIRUS VACCINE, LIVE, ORAL, TYPE G3 (HUMAN) 0.0002 UNIT per DOSE
- ROTAVIRUS VACCINE, LIVE, ORAL, TYPE G4 (HUMAN) 0 UNIT per DOSE
- ROTAVIRUS VACCINE, LIVE, ORAL, TYPE P1(8) (HUMAN) 7 UNIT per DOSE